Bevacizumab-Containing Chemoimmunotherapy for Recurrent Non-Small-Cell Lung Cancer after Chemoradiotherapy: Case Report

Chemoimmunotherapy has become the standard of care as the first-line treatment of advanced or recurrent non-small-cell lung cancer (NSCLC). The bevacizumab-containing chemoimmunotherapy regimen is theoretically more effective than a non-bevacizumab-containing regimen via two mechanisms: a superior o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicina (Kaunas)
Main Authors: Kataoka, Nobutaka, Kunimatsu, Yusuke, Tsutsumi, Rei, Tani, Nozomi, Sato, Izumi, Tanimura, Mai, Nakano, Takayuki, Tanimura, Keiko, Kato, Daishiro, Takeda, Takayuki
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8226573/
https://ncbi.nlm.nih.gov/pubmed/34072448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina57060547
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados